LYNETTE MARIE MOORE

TitleInstructor
InstitutionMD Anderson
DepartmentNeurosurgery
Address6767 Bertner St
Houston TX 77030-2603
vCardDownload vCard

    Collapse ORNG Applications 
    Collapse Verify Publications

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Moore LM, Zhang W. MIR-491: CDKN2A tumor suppressor co-pilot. Oncoscience. 2015; 2(10):825-6. PMID: 26682264.
      Citations: 1     
    2. Li X, Liu Y, Granberg KJ, Wang Q, Moore LM, Ji P, Gumin J, Sulman EP, Calin GA, Haapasalo H, Nykter M, Shmulevich I, Fuller GN, Lang FF, Zhang W. Two mature products of MIR-491 coordinate to suppress key cancer hallmarks in glioblastoma. Oncogene. 2015 Mar 26; 34(13):1619-1628. PMID: 24747968.
      Citations: 35     Fields:    Translation:HumansAnimalsCells
    3. Li J, Chen GS, Zhang X, Moore L, Cheng H. Congenital cystic adenomatoid malformation with associated mucinous bronchioloalveolar carcinoma in a neonate. Fetal Pediatr Pathol. 2014 Feb; 33(1):29-34. PMID: 24093545.
      Citations: 4     Fields:    Translation:Humans
    4. Zhang C, Moore LM, Li X, Yung WK, Zhang W. IDH1/2 mutations target a key hallmark of cancer by deregulating cellular metabolism in glioma. Neuro Oncol. 2013 Sep; 15(9):1114-26. PMID: 23877318.
      Citations: 52     Fields:    Translation:Humans
    5. Moore LM, Kivinen V, Liu Y, Annala M, Cogdell D, Liu X, Liu CG, Sawaya R, Yli-Harja O, Shmulevich I, Fuller GN, Zhang W, Nykter M. Transcriptome and small RNA deep sequencing reveals deregulation of miRNA biogenesis in human glioma. J Pathol. 2013 Feb; 229(3):449-59. PMID: 23007860.
      Citations: 12     Fields:    Translation:HumansCells
    6. Holmes KM, Annala M, Chua CY, Dunlap SM, Liu Y, Hugen N, Moore LM, Cogdell D, Hu L, Nykter M, Hess K, Fuller GN, Zhang W. Insulin-like growth factor-binding protein 2-driven glioma progression is prevented by blocking a clinically significant integrin, integrin-linked kinase, and NF-?B network. Proc Natl Acad Sci U S A. 2012 Feb 28; 109(9):3475-80. PMID: 22345562.
      Citations: 54     Fields:    Translation:HumansAnimalsCells
    7. Zhang W, Moore L, Ji P. Mouse models for cancer research. Chin J Cancer. 2011 Mar; 30(3):149-52. PMID: 21352691.
      Citations: 4     Fields:    Translation:HumansAnimalsCells
    8. Moore LM, Holmes KM, Fuller GN, Zhang W. Oncogene interactions are required for glioma development and progression as revealed by a tissue specific transgenic mouse model. Chin J Cancer. 2011 Mar; 30(3):163-72. PMID: 21352693.
      Citations: 1     Fields:    Translation:HumansAnimalsCells
    9. Moore LM, Zhang W. Targeting miR-21 in glioma: a small RNA with big potential. Expert Opin Ther Targets. 2010 Nov; 14(11):1247-57. PMID: 20942748.
      Citations: 20     Fields:    Translation:HumansAnimals
    10. Zhou X, Ren Y, Moore L, Mei M, You Y, Xu P, Wang B, Wang G, Jia Z, Pu P, Zhang W, Kang C. Downregulation of miR-21 inhibits EGFR pathway and suppresses the growth of human glioblastoma cells independent of PTEN status. Lab Invest. 2010 Feb; 90(2):144-55. PMID: 20048743.
      Citations: 137     Fields:    Translation:HumansAnimalsCells
    11. Higgins RJ, Dickinson PJ, LeCouteur RA, Bollen AW, Wang H, Wang H, Corely LJ, Moore LM, Zang W, Fuller GN. Spontaneous canine gliomas: overexpression of EGFR, PDGFRalpha and IGFBP2 demonstrated by tissue microarray immunophenotyping. J Neurooncol. 2010 May; 98(1):49-55. PMID: 19967449.
      Citations: 31     Fields:    Translation:Animals
    12. Moore LM, Holmes KM, Smith SM, Wu Y, Tchougounova E, Uhrbom L, Sawaya R, Bruner JM, Fuller GN, Zhang W. IGFBP2 is a candidate biomarker for Ink4a-Arf status and a therapeutic target for high-grade gliomas. Proc Natl Acad Sci U S A. 2009 Sep 29; 106(39):16675-9. PMID: 19805356.
      Citations: 29     Fields:    Translation:HumansAnimalsCells
    13. Moore L, Lu X, Ghebranious N, Tyner S, Donehower LA. Aging-associated truncated form of p53 interacts with wild-type p53 and alters p53 stability, localization, and activity. Mech Ageing Dev. 2007 Nov-Dec; 128(11-12):717-30. PMID: 18061646.
      Citations: 18     Fields:    Translation:HumansAnimalsCells
    14. Gatza C, Moore L, Dumble M, Donehower LA. Tumor suppressor dosage regulates stem cell dynamics during aging. Cell Cycle. 2007 Jan 01; 6(1):52-5. PMID: 17245110.
      Citations: 15     Translation:HumansAnimalsCells
    15. Dumble M, Moore L, Chambers SM, Geiger H, Van Zant G, Goodell MA, Donehower LA. The impact of altered p53 dosage on hematopoietic stem cell dynamics during aging. Blood. 2007 Feb 15; 109(4):1736-42. PMID: 17032926.
      Citations: 106     Fields:    Translation:AnimalsCells
    16. Knisely AS, Strautnieks SS, Meier Y, Stieger B, Byrne JA, Portmann BC, Bull LN, Pawlikowska L, Bilezikçi B, Ozçay F, László A, Tiszlavicz L, Moore L, Raftos J, Arnell H, Fischler B, Németh A, Papadogiannakis N, Cielecka-Kuszyk J, Jankowska I, Pawlowska J, Melín-Aldana H, Emerick KM, Whitington PF, Mieli-Vergani G, Thompson RJ. Hepatocellular carcinoma in ten children under five years of age with bile salt export pump deficiency. Hepatology. 2006 Aug; 44(2):478-86. PMID: 16871584.
      Citations: 89     Fields:    Translation:Humans
    17. Moore L, Venkatachalam S, Vogel H, Watt JC, Wu CL, Steinman H, Jones SN, Donehower LA. Cooperativity of p19ARF, Mdm2, and p53 in murine tumorigenesis. Oncogene. 2003 Oct 30; 22(49):7831-7. PMID: 14586409.
      Citations: 17     Fields:    Translation:Animals
    18. IGFBP2 potentiates nuclear EGFR-STAT3 signaling. Oncogene. 35:738-747.
    19. MIR-491. Oncoscience. 2:825-826.
    20. p53 and Mouse Aging Models. 149-180.
    MOORE's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (117)
    Explore
    _
    Co-Authors (12)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _